Send the following on WhatsApp
Continue to Chathttps://www.efe.com/efe/usa/comunicados/junshi-biosciences-announces-acceptance-by-the-nmpa-of-supplemental-new-drug-application-for-toripalimab-combined-with-chemotherapy-first-line-treatment/50000209-MULTIMEDIAE_4468946